Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
donepezil (aricept) (1 trial)
encenicline (1 trial)
rivastigmine (exelon) (1 trial)
Alzheimer Disease (Phase 1)
Central Nervous System Diseases (Phase 1)
Nervous System Diseases (Phase 1)
Trials (1 total)
Trial APIs (3 total)